My ePortfolio Register   
 

Abstract | Full HTML Article | PDF | Spanish ecancer 8 435 / DOI: 10.3332/ecancer.2014.435

Review

Focal therapy in prostate cancer: the current situation

Prostate cancer is one of the most significant pathologies in the field of urology. The adoption of screening strategies and improvements in biopsies have resulted in an increase in early-stage tumour detection.

Radical global therapies provide very good oncological results in localised prostate cancer. However, excess treatment in low- and, in some cases, intermediate-risk groups affects the quality of life of these patients.

In the case of localised prostate cancer, focal therapies offer a minimally invasive option with good results with respect to established treatments. Although this is currently not a standard treatment, it represents the therapeutic approach with the greatest potential.

This literature review has the following objectives: to define selection criteria for patients who are candidates for focal therapy, to assess the current situation and results of the different therapeutic options, and to define procedures in cases of recurrence and for follow-ups.

We concluded that focal therapy is a viable therapeutic alternative for localised prostate cancer, specifically cryosurgery and high-intensity targeted ultrasound, which have acceptable oncologic results and a lower comorbidity compared with global treatments. Studies with a high level of scientific evidence are still needed to validate these results.

Acquisition of evidence: A search was carried out on the Medline (PubMed), EMBASE, Web of Science and Cochrane databases of all papers published before 31 July 2013. We included clinical studies and literature reviews that evaluated primary focal therapy for prostate cancer confirmed by biopsy and excluded focal rescue therapy studies. The keywords used were focal therapy and prostate cancer.

Initially, we found 42 articles; 15 studies were excluded because they did not meet the minimum criteria for inclusion. A total of 1350 cases were treated throughout 27 studies.

Keywords: localised prostate cancer, focal therapy

Loading Article Metrics ... Please wait

Related articles

Research: Serum biomarkers to predict risk of testicular and penile cancer in AMORIS

Abstract | Full Article | PDF Published: 23 Aug 2017 / DOI: 10.3332/ecancer.2017.762

Case Report: Malignant extra-adrenal pelvic paraganglioma in a paediatric patient

Abstract | Full Article | PDF | Spanish Published: 23 Aug 2017 / DOI: 10.3332/ecancer.2017.761

Case Report: Resection of rectal GIST using a novel technique: a report of two cases

Abstract | Full Article | PDF Published: 17 Aug 2017 / DOI: 10.3332/ecancer.2017.760

Case Report: Metastasizing pleomorphic adenoma of the parotid gland

Abstract | Full Article | PDF Published: 15 Aug 2017 / DOI: 10.3332/ecancer.2017.758

Research: Clinical, epidemiological, and therapeutic profile of patients with a retinoblastoma diagnosis experience in the Costa Rica National Children’s Hospital Oncology Unit from January 2009 to December 2015

Abstract | Full Article | PDF Published: 24 Jul 2017 / DOI: 10.3332/ecancer.2017.754



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence